200 related articles for article (PubMed ID: 16854058)
1. Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.
Dayam R; Aiello F; Deng J; Wu Y; Garofalo A; Chen X; Neamati N
J Med Chem; 2006 Jul; 49(15):4526-34. PubMed ID: 16854058
[TBL] [Abstract][Full Text] [Related]
2. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.
Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C
Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacophore model of integrin alphavbeta3 antagonists].
Cheng GY; Ni GH; Jiang FC
Yao Xue Xue Bao; 2009 Apr; 44(4):379-85. PubMed ID: 19545055
[TBL] [Abstract][Full Text] [Related]
4. [Design and activity determination of small molecular inhibitors of integrin alphavbeta3].
Ji Q; Zhou Y; Peng H; Huang N; Qi J; Xiong DS; Gao YD; Yang M; Yang CZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):347-52. PubMed ID: 17633460
[TBL] [Abstract][Full Text] [Related]
5. Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases.
Braña MF; Cacho M; García ML; Mayoral EP; López B; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Lozach O; Meijer L
J Med Chem; 2005 Nov; 48(22):6843-54. PubMed ID: 16250643
[TBL] [Abstract][Full Text] [Related]
6. Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: preliminary control of alphavbeta3 selectivity by meta-oriented substitution.
Kubota D; Ishikawa M; Ishikawa M; Yahata N; Murakami S; Fujishima K; Kitakaze M; Ajito K
Bioorg Med Chem; 2006 Jun; 14(12):4158-81. PubMed ID: 16504518
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach.
Gundla R; Kazemi R; Sanam R; Muttineni R; Sarma JA; Dayam R; Neamati N
J Med Chem; 2008 Jun; 51(12):3367-77. PubMed ID: 18500794
[TBL] [Abstract][Full Text] [Related]
8. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
[TBL] [Abstract][Full Text] [Related]
9. Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.
Raboisson P; Manthey CL; Chaikin M; Lattanze J; Crysler C; Leonard K; Pan W; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2006 Jul; 41(7):847-61. PubMed ID: 16697080
[TBL] [Abstract][Full Text] [Related]
10. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel anticancer compounds based on a quinoxalinehydrazine pharmacophore.
Deng J; Taheri L; Grande F; Aiello F; Garofalo A; Neamati N
ChemMedChem; 2008 Nov; 3(11):1677-86. PubMed ID: 18985651
[TBL] [Abstract][Full Text] [Related]
12. N-Aryl-gamma-lactams as integrin alphavbeta3 antagonists.
Xi N; Arvedson S; Eisenberg S; Han N; Handley M; Huang L; Huang Q; Kiselyov A; Liu Q; Lu Y; Nunez G; Osslund T; Powers D; Tasker AS; Wang L; Xiang T; Xu S; Zhang J; Zhu J; Kendall R; Dominguez C
Bioorg Med Chem Lett; 2004 Jun; 14(11):2905-9. PubMed ID: 15125957
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V; Welsh W; Arora S; Farruggia G; Masotti L
J Med Chem; 2005 Aug; 48(17):5604-7. PubMed ID: 16107161
[TBL] [Abstract][Full Text] [Related]
14. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
Dayam R; Sanchez T; Neamati N
J Med Chem; 2005 Dec; 48(25):8009-15. PubMed ID: 16335925
[TBL] [Abstract][Full Text] [Related]
15. Combined pharmacophore and structure-guided studies to identify diverse HSP90 inhibitors.
Sanam R; Tajne S; Gundla R; Vadivelan S; Machiraju PK; Dayam R; Narasu L; Jagarlapudi S; Neamati N
J Mol Graph Model; 2010 Feb; 28(6):472-7. PubMed ID: 20005756
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity.
Subtel'na I; Atamanyuk D; Szymańska E; Kieć-Kononowicz K; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
Bioorg Med Chem; 2010 Jul; 18(14):5090-102. PubMed ID: 20594860
[TBL] [Abstract][Full Text] [Related]
17. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds.
Hou Z; Nakanishi I; Kinoshita T; Takei Y; Yasue M; Misu R; Suzuki Y; Nakamura S; Kure T; Ohno H; Murata K; Kitaura K; Hirasawa A; Tsujimoto G; Oishi S; Fujii N
J Med Chem; 2012 Mar; 55(6):2899-903. PubMed ID: 22339433
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 1-(3',4',5'-trimethoxy) phenyl naphtho[2,1b]furan as a novel anticancer agent.
Srivastava V; Negi AS; Kumar JK; Faridi U; Sisodia BS; Darokar MP; Luqman S; Khanuja SP
Bioorg Med Chem Lett; 2006 Feb; 16(4):911-4. PubMed ID: 16297622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
